Edgestream Partners, L.P. Revolution Medicines, Inc. Transaction History
Edgestream Partners, L.P.
- $2.88 Billion
- Q1 2025
A detailed history of Edgestream Partners, L.P. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Edgestream Partners, L.P. holds 215,717 shares of RVMD stock, worth $7.98 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
215,717
Previous 7,779
2673.07%
Holding current value
$7.98 Million
Previous $340,000
2143.24%
% of portfolio
0.27%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding RVMD
# of Institutions
303Shares Held
189MCall Options Held
186KPut Options Held
672K-
Vanguard Group Inc Valley Forge, PA16.6MShares$614 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.5MShares$501 Million2.75% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$496 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$436 Million0.08% of portfolio
-
Janus Henderson Group PLC London, X010.2MShares$377 Million0.21% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.24B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...